Company intelligence / Profile preview

Yide Biotechnology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Yide Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and commercialization of innovative vaccines and therapeutic biologics. The company leverages a proprietary recombinant protein expression platform to target high-burden infectious diseases and oncology indications. Its primary focus includes the development of next-generation HPV vaccines and therapeutic candidates for chronic hepatitis B. Yide Biotechnology aims to address significant unmet medical needs in the domestic Chinese market through advanced biotechnology solutions.

Therapeutic areas: Infectious DiseasesOncology
Modalities: BiologicVaccineRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Yide Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yide Biotechnology.

Explore the full profile